enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Joint British Diabetes Societies for Inpatient Care group

    en.wikipedia.org/wiki/Joint_British_Diabetes...

    [3] [4] The guidelines have been widely used across the UK and helped reduce variations by standardising approach to inpatient diabetes care. [1] Hypoglycaemia [5] Diabetic Ketoacidosis (DKA) in Adults [6] Hyperosmolar hyperglycemia state (HHS) in adults with diabetes [7] Glycaemic control in people with cancer [8] Diabetes at the front door [9]

  3. List of Guidances for Statistics in Regulatory Affairs

    en.wikipedia.org/wiki/List_of_Guidances_for...

    FDA: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes [40] provides recommendations for the development of drugs and therapeutic biologics regulated within the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA) for the treatment of diabetes mellitus. Specifically, this guidance ...

  4. Continuous glucose monitor - Wikipedia

    en.wikipedia.org/wiki/Continuous_glucose_monitor

    UK NICE guidelines introduced for the NHS in March 2022 in England and Wales advise that all Type 1 diabetic patients should be offered either flash glucose monitoring or CGM. People with Type 2 diabetes should be offered flash glucose monitoring or CGM if they use insulin twice daily or more, are otherwise advised to finger-prick eight times a ...

  5. National Institute for Health and Care Excellence - Wikipedia

    en.wikipedia.org/wiki/National_Institute_for...

    Patients on the new treatment on average live an extra 3 months, so 1.25 years in total. The quality of life gained is the product of life span and quality rating with the new treatment less the same calculation for the old treatment, i.e. (1.25 x 0.6) less (1.0 x 0.4) = 0.35 QALY. The marginal cost of the new treatment to deliver this extra ...

  6. Type 1 diabetes - Wikipedia

    en.wikipedia.org/wiki/Type_1_diabetes

    Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that occurs when pancreatic cells (beta cells) are destroyed by the body's immune system. [5] In healthy persons, beta cells produce insulin. Insulin is a hormone required by the body to store and convert blood sugar into energy. [6]

  7. Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript - AOL

    www.aol.com/abbott-laboratories-abt-q4-2024...

    In diabetes care, sales of continuous glucose monitors were $1.8 billion in the quarter and grew 23%. ... Oh, great. Thanks for taking the question, and congrats on a nice quarter and guide. And ...

  8. Blood glucose monitoring - Wikipedia

    en.wikipedia.org/wiki/Blood_glucose_monitoring

    Furthermore, a recent study showed that patients described as being "Uncontrolled Diabetics" (defined in this study by HbA1C levels >8%) showed a statistically significant decrease in the HbA1C levels after a 90-day period of seven-point self-monitoring of blood glucose (SMBG) with a relative risk reduction (RRR) of 0.18% (95% CI, 0.86–2.64% ...

  9. DESMOND (diabetes) - Wikipedia

    en.wikipedia.org/wiki/DESMOND_(diabetes)

    DESMOND is the first national education programme created for people with Type 2 diabetes. DESMOND meets the criteria NICE identified as being the characteristics of a quality, evidence-based structured education programme. A NHS training course is available for type 1 diabetics called DAFNE (Dose Adjustment for Normal Eating).